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Abstract We investigated the antigenic determinants of factors adherence of Candida cells to mammalian tissues during the 
8, 9, and 34 of the genus Candida among pathogenic yeasts by initial step of infection [11]. Therefore, the cell wall compo- 
enzyme-linked immunosorbent assay (ELISA) using mannans of nents containing mannose residues in the o~ configuration 
Saccharomyces cerevisiae wild type and mutant types, mnn 1- must be structurally and immunochemically characterized to 
mnn 4 and mnn 2. Results of ELISA including antisera against help understand these host-parasite interactions. The antigenic 
the antigenic factors of genus Candida (Candida Check, Iatron; determinants of factors 1 and 4 are linear cz-l,2-1inked oligo- 
FAbs) indicated that these three types of mannan distinctly react mannosyl [12] and 3,6-branched oligomannosyl units [13], re- 
with FAbs 34, 8 and 9, respectively. To identify the recognition spectively. However, those of factors 8 and 34 corresponding 
sites of these FAbs, we compared the ability of various to the specific antigens of Candida kefyr and Candidaglabrata, 
oligosaccharides to inhibit the binding of the mannans to FAbs. which seemed to be a-linked oligomannosyl units, have not 
The results indicated that FAb 34 preferentially recognizes linear been identified. Here, we show that Saccharomyces cerevisiae 
side chains containing a non-reducing terminal a-l,3-1inked 
mannose residue, Mana l  ~ 3Mana l  ~ (2Mana l  ~)n2Man wild and mutant-type mannans are recognized by several anti- 
(n -> 0), and that one of the recognition sites of FAb 9 is linear sera to factors of the genus Candida and that the antigenic 
a-l,6-1inked oligomannosyl series, Mana l  ~(6Mana l  ~)n6-  determinants correspond to specific a-linked oligomannosyl 
Man (n -> 2). On the other hand, the recognition site of FAb 8 units. 
apparently consisted of two a-l,2-1inked oligomannosyl side 
chains and an a-l,6-1inked mannose residue that originated from 2. Materials and methods 
the mannan backbone, Mana l -~ 2Manal ~2(Manot l - *  2- 
Manctl --* 6)Man. 2.1. Strains and culture 
S. cerevisiae wild type (X2180-1A; referred to as strain 1A) [14] and 
Key words." Pathogenic genus Candida; Saccharomyces S. cerevisiae mnn 1-mnn 4 and mnn 2 mutant ypes (4484-24-D-1 and 
cerevisiae; Cell wall mannan; Antigenic factor; X2180-1A-5; referred as strains D1 and A5, respectively) [15] were 
Enzyme-linked immunosorbent assay gifts from Dr. T. Nakajima, Tohoku University, Sendai, Japan. C. 
kefyr (IFO 0586; strain K) [12] was obtained from the Institute for 
Fermentation Osaka (IFO), Osaka, Japan. These strains were culti- 
vated in yeast extract-Sabouraud's liquid medium (0.5% (w/v) yeast 
1. Introduction extract, 1% (w/v) peptone, and 2% (w/v) o-glucose) at 27°C for 72 h 
on a reciprocal shaker. 
Tsuchiya et al. [1] originally proposed that there is an im- 2.2. Preparation ofmannans 
munochemical relationship among clinically significant species Mannans were extracted using hot water and precipitated with 
of the genus Candida, based on 10 cell surface antigenic fac- Fehling solution [16]. The purified mannan fractions obtained from 
strains 1A, D1, A5, and K were designated Frs. IA, D1, A5, and K, 
tors. Thereafter, the Candida Check kit (Iatron, Japan) that respectively. The yields of Frs. 1A, D1, A5, and K were 7.8%, 7.2%, 
included rabbit antisera to factors of the genus Candida was 7.3% and 6.0% of the dry cell weight, respectively. The structures of 
developed to identify clinical isolates from the candidiasis pa- these mannans confirmed by 1H-nuclear magnetic resonance (1H- 
tients [2]. NMR) [17,18] are shown in Fig. 1. 
We showed that the antigenic determinants of factors 5, 6, 2.3. Enzyme-linked immunosorbent assay (ELISA) ofmannans 
and 9 correspond to three side chains containing ~-l,2-1inked Antisera against factors 1, 6, 8, 9, and 34 of the genus Candida 
mannose residue in cell wall mannan [3-5]. These side chains, (FAbs 1, 6, 8, 9, and 34, respectively) were supplied with the Candida 
which reside only in the genus Candida among all the patho- Check kits (lot nos. 1-571 and R-572, Iatron, Tokyo, Japan). FAb 6, 
genic yeasts, have been investigated for use as the target anti- which recognizes [3-1,2-1inked mannose residue [4], was used as a 
negative control. Sera were diluted from 9- to 19683-fold with phos- 
gen in diagnosing invasive candidiasis [6]. Although [3-1,2- phate-buffered saline containing 0.1% (w/v) Tween 20 (PBST). ELISA 
linked oligomannosyl units are involved in the induction of was performed according to a previously described procedure [3]. 
cytokines uch as TNF  [7,8], the a-linked mannooligosacchar- 
ides obtained from Candida mannan were potent inhibitors of 2.4. ELISA inhibition using mannooligosaccharides 
lymphoproliferation i duced by the parent mannan [9,10]. A series of a-l,2-1inked oligosaccharides, biose (M2-2) to tetraose 
(M4-2), was prepared from Frs. 1A, D1, K, and C. albicans mannans 
Furthermore, the a-linked units seem to participate in the [16] by conventional acetolysis [19]. The a-l,6-1inked series, triose 
(M3-6) to pentaose (M5-6), was prepared from Fr. A5 [17] by mild 
acetolysis [16]. Oligosaccharides containing a non-reducing terminal 
*Corresponding author. Fax: (81) (22) 275-2013. a-l,3-1inkage, triose (M3-3) to pentaose (M5-3), were prepared from 
Fr. 1A and Candida stellatoidea type I [20] and Candida krusei man- 
1Present address." Sendai Research Institute for Mycology, nans (Oyamada et al., unpublished) by mild acetolysis. A hexaose 
1-14-34 Tohshogu, Aoba-ku, Sendai, Miyagi 981, Japan. containing an internal a-l,3-1inkage (M6-2,3) was prepared from 
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Fig. 1. ELISA of S. cerevisiae mannans, Fr. 1A (A), Fr. DI (B), Fr. A5 (C), and Fr. K (D) with FAb 1 (©), FAb 6 (zx), FAb 8 (e), FAb 9 
(•) ,  and FAb 34 (11). The structure of each mannan is shown in the upper part of the corresponding graph. M denotes a o-mannose residue. 
C. stellatoidea type I mannan by conventional cetolysis. A pentaose from both results and published mannan structures of C. 
containing an a-l,6-1inkage (M5-2,6) was prepared from Frs. D1 and glabrata [23] and C. albicans [13]. During biosynthesis of C. 
K by mild acetolysis. A 3,6-branched pentaose (M5-3,6) was synthe- 
sized from M4-3 by an enzymatic procedure using GDP-mannose and glabrata mannan (Fig. 3A), the side chain corresponding to 
an c~-l,6-mannosyltransferase of C. albicans serotype B [21]. The che- the antigenic determinant of factor 34 appears to be prefer- 
mical structures of the oligosaccharides were confirmed by 1H-NMR entially synthesized compared to that of antigenic factor 6. On 
[13,18] and are shown in Table 1. The negative control, o-mannose the other hand, during biosynthesis of C. albicans mannan 
(Sigma), and the inhibitors were diluted with PBST. The inhibition (Fig. 3B), the intermediate side chain corresponding to factor 
assay was performed according to Okawa et al. [22] with modification. 
FAbs 8, 9, and 34 were diluted 10-, 200-, and 20-fold with PBST, 34 appears to be quickly presented as a substrate for the 
based on the ELISA results of Frs. D1, A5, and 1A, respectively. 
Diluted FAb, 50 gl, was incubated for 2 h at 30°C in the presence Table 1 
of 50 gl of inhibitor. This mixture was then added to the wells of Chemical structures of mannooligosaccharides used for ELISA 
microtiter plates coated with mannan, and the plates were processed inhibition assay 
as described by Shibata et al. [3]. The inhibition ratio (%) was calcu- 
lated using the formula: Inhibition (%)=(1-A/B)× 100, where A and Abbreviation Structure of inhibitor a
B are the optical densities at 492 nm with and without inhibitor, 
respectively. 
M2-2 Manet 1--~2Man 
3. Resu l ts  and d iscuss ion  M3-2 Manctl--~2Manal--,2Man 
M4-2 Mann 1 ~ (2Man~x 1---~)22Man 
The results of ELISA of Fr. 1A indicate that FAbs 1 and 34 M3-6  Manctl---~6Manctl---~6Man 
are highly reactive, whereas FAbs 8 and 9 are only slightly M, -6  Manctl~(6Mancxl~)26Man 
reactive (Fig. 1A). This finding suggests that the recognition M, -6  Mana1-~(6Manctl---~)36Man 
site of FAb 34 resides in the tetraosyl side chain containing M3-3  Manctl~3Manctl---,2Man 
the non-reducing terminal ~x-l,3-1inked mannose residue, be- M,-3 Manctl~3Manetl-~2Manctl~2Man 
cause short a-l,2-1inked oligomannosyl side chains are the M5.3 Manal~3Manal--+(2Manal~)z2Man 
recognition sites of FAb 1 [12]. The results of ELISA-inhibi- M , -2 ,6  Manctl---~2Manctl~2Man 
tion of Fr. 1A with diluted FAb 34 show that M3-3, M4-3, . a l  6 
and M5-3 inhibit the binding of this serum (Fig. 2A). These manctl~2Man 
results indicate that FAb 34 recognizes a non-reducing termi- 
nal c~-l,3-1inked mannose residue but not the exact length of M5"3'6 Manetl---~3Manal--*2Manc~l--*2Manctl 6 
the inner c~-l,2-1inked oligomannosyl unit. M5-3,6 did not Man 
inhibit under the same conditions, indicating that FAb 34 M6-2,3 Man ct 1---~ 2Man ct 1---~ 3 Man c~ 1 ---~ (2 Manct 1---~ ) z2 Man 
does not recognize the 3,6-branched side chain corresponding 
to the antigenic determinant of factor 4 [13]. The biosynthetic ~ Man denotes a o-mannose residue. Chemical structures of oligosac- 
pathways of antigenic factors shown in Fig. 3 were inferred charides were determined based on 1H-NMR assignments [13,16,18]. 
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Fig. 2. ELISA inhibition assays of Fr. 1A with FAb 34 (A), Fr. D1 with FAb 8 (B), Fr. A5 with FAb 9 (C), and Fr. K with FAb 8 (D) using 
oligosaccharides, M2-2 (©), M3-2 (zx), M4-2 ([3), M3-6 (O), M4-6 (A), M5-6 (11), M3-3 (~), M4-3 (•), M5-3 (Iq), M~-2,6 (@), M~-3,6 (f-II), 
and M6-2,3 (~k), and D-mannose (negative control) (×). 
downstream enzyme, e~-l,6-mannosyltransferase, which par- support the findings of Ataoglu et al. [25] who defined the 
ticipates in the synthesis of antigenic factor 4 [13] and requires determinant of FAb 9 as a linear c~-l,6-1inked mannose poly- 
a side chain possessing a non-reducing terminal c~-l,3-1inked mer. In addition to their findings, the results of ELISA-inhi- 
mannose residue in C. albicans mannan [21]. As a result of bition assay of Fr. A5 with FAb 9 (Fig. 2C) indicate that the 
this biosynthetic process in C. albicans mannan, antigenic recognition size of FAb 9 is a linear c~-l,6-1inked oligoman- 
factor 34 was not detected using FAb 34 [2]. nosyl unit consisting of over three residues. However, it 
We postulated that the immunodominant of FAb 8 resides should be stressed that the true antigenic determinants of
in C. kefyr cell surface molecules other than the mannan [12]. factor 9 are the specific side chains in Candida guilliermondii 
On the other hand, Fukazawa et al. [24] reported that anti- mannan corresponding to Man[~l--*2Manl31 ~2Mancd ~3-  
genic factor 8 corresponds to the a-l,2-1inked mannobiosyl Maned ~ 2Manal ~ 3Man~l ~2Mana l  ~2Man,  Man- 
side chain of C. kefyr mannan. However, these conclusions 131 ~ 2Manl]l -~ 2Manal ~ 3Manal ~ 2Manal ~ 2Man, and 
should be revised according to the findings presented here. their branched forms substituted with an c~-l,6-1inked man- 
Fig. 1B,D shows that FAbs 1 and 8 recognize Frs. D1 and nose residue [5]. We have previously demonstrated that the 
K, whereas FAbs 9 and 34 does not. In addition, M5-2,6 density of side chains substituting to the ~-l,6-1inked mannan 
similarly inhibited the binding of FAb 8 to these mannans backbone of C. albicans IFO 1060 is remarkably higher than 
(Fig. 2B,D), indicating that one of the determinants of FAb that of C. guilliermondii IFO 10278 [5,26]. Therefore, FAb 9 is 
8 is a unit consisting of two short a-l,2-1inked oligomannosyl not monospeeific since it was prepared simply by absorbing 
side chains and an a-l,6-1inked mannose residue that origi- anti-IFO 10278 whole-cell serum with cells of the IFO 1060 
nated from the mannan backbone. However, the possibility [1]. 
remains that FAb 8 requires other component(s), such as a 
larger molecule(s) composed of side chains joined by more 
than one c~-l,6-1inkage, which could not be prepared in this References 
and prior studies. Despite the presence of an ~-l,2-1inked 
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Fig. 3. Postulated pathway for biosynthesis of side chains corresponding to antigenic factors in cell wall mannans of C. glabrata (A) and C. al- 
bicans serotype A (B). M denotes a D-mannose residue. 
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